ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesI42.4

I42.4

Billable

Endocardial fibroelastosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 I42.4 is a billable code used to indicate a diagnosis of endocardial fibroelastosis.

Key Diagnostic Point:

Endocardial fibroelastosis (EFE) is a rare cardiac condition characterized by the thickening of the endocardium, primarily affecting the left ventricle. This condition is often seen in infants and young children, particularly those with congenital heart defects. Clinically, patients may present with symptoms of heart failure, including dyspnea, fatigue, and poor growth. The anatomy involved includes the endocardial layer of the heart, which becomes fibrotic and elastotic, leading to impaired cardiac function. Disease progression can vary, but untreated EFE can lead to severe heart failure and arrhythmias. Diagnosis typically involves echocardiography, which reveals thickened endocardial layers and may show associated ventricular dilation. MRI and cardiac catheterization may also be utilized for further assessment. Early diagnosis and intervention are crucial to improve outcomes, as the condition can lead to significant morbidity and mortality if not managed appropriately.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires specialized imaging and clinical evaluation.
  • Treatment complexity: May involve medical management and surgical interventions.
  • Documentation requirements: Detailed clinical history and imaging results are essential.
  • Coding specificity: Requires precise coding to differentiate from other cardiomyopathies.

Audit Risk Factors

  • Common coding errors: Misclassification with other cardiomyopathies.
  • Documentation gaps: Incomplete clinical history or imaging reports.
  • Billing challenges: Potential denials due to lack of specificity in documentation.

Specialty Focus

Medical Specialties

Cardiology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Pediatrics

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Endocardial fibroelastosis has significant clinical implications, particularly in pediatric populations where it can lead to severe heart failure and increased healthcare utilization. Understanding the epidemiology of EFE is crucial, as it is often associated with congenital heart defects. Quality measures focus on early diagnosis and intervention, which can improve outcomes and reduce long-term complications. Population health initiatives aim to raise awareness and improve screening for this rare condition.

ICD-9 vs ICD-10

Endocardial fibroelastosis has significant clinical implications, particularly in pediatric populations where it can lead to severe heart failure and increased healthcare utilization. Understanding the epidemiology of EFE is crucial, as it is often associated with congenital heart defects. Quality measures focus on early diagnosis and intervention, which can improve outcomes and reduce long-term complications. Population health initiatives aim to raise awareness and improve screening for this rare condition.

Reimbursement & Billing Impact

Reimbursement considerations include the need for detailed clinical notes that justify the medical necessity of echocardiography and any potential surgical interventions. Common denials may arise from insufficient documentation or failure to demonstrate the specific nature of the condition. Best practices include ensuring that all imaging results and clinical evaluations are clearly documented and linked to the diagnosis to support claims.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for I00-I99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for I00-I99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by I42.4?

I42.4 specifically covers endocardial fibroelastosis, which is characterized by the thickening of the endocardium. It is often associated with congenital heart defects and can lead to heart failure.

When should I42.4 be used instead of related codes?

I42.4 should be used when a patient has a confirmed diagnosis of endocardial fibroelastosis, particularly when imaging studies demonstrate the characteristic endocardial thickening, distinguishing it from other forms of cardiomyopathy.

What documentation supports I42.4?

Documentation should include clinical findings, echocardiographic evidence of endocardial thickening, and any relevant history of congenital heart disease. Detailed notes on symptoms and treatment plans are also necessary.